The global flow cytometry market is set to achieve robust growth, reflecting its critical role in both research and clinical applications. The market revenue, valued at USD 5,985.8 million in 2023, is anticipated to reach USD 6,376.7 million in 2024, showcasing a year-on-year (Y-o-Y) growth of 7.2%. Over the next decade, the industry is projected to grow at a compound annual growth rate (CAGR) of 7.1%, reaching an impressive USD 12,661.7 million by 2034.
Flow cytometry is a sophisticated laboratory process that analyzes the physical and chemical properties of cells or particles in a fluid stream using laser technology. By staining cells with fluorescent dyes targeting specific cellular elements, this technique enables rapid and precise identification of various cell types and states. The capability to analyze thousands of cells per second makes flow cytometry indispensable for applications in immunology, cancer research, and clinical diagnostics.
The consistent adoption of flow cytometry is driven by advancements in technology, expanding applications in drug discovery, and its increasing relevance in precision medicine. Its dual utility in research and clinical settings ensures its pivotal role in advancing healthcare innovation.
Key Takeaways:
- The global flow cytometry market is expected to grow from USD 5,985.8 million in 2023 to USD 6,376.7 million in 2024, reflecting a 7.2% Y-o-Y growth.
- With a CAGR of 7.1%, the market is projected to reach USD 12,661.7 million by 2034.
- Flow cytometry enables high-speed analysis of cell properties, supporting both research and clinical diagnostics.
- Key growth drivers include advancements in cell analysis technologies, expanding applications in healthcare, and growing demand for precision medicine.
As the demand for rapid and accurate cell analysis continues to rise, flow cytometry is well-positioned to remain a cornerstone of modern laboratory science and clinical practice.
A Full Report Analysis –
https://www.futuremarketinsights.com/reports/flow-cytometry-market
Overview of Flow Cytometry
Flow cytometry is a laboratory technique used to analyze the physical and chemical properties of cells or particles as they pass through a laser beam in a fluid stream. This method allows for the rapid analysis of thousands of cells per second, making it highly efficient for both research and clinical applications. Cells are typically stained with fluorescent dyes that bind to specific cellular components, enabling the detection and quantification of various cell types and states.
Applications of Flow Cytometry
- Immunophenotyping: This is one of the most common applications, used to identify and quantify different cell populations in blood and bone marrow samples. It plays a crucial role in diagnosing hematological malignancies such as leukemia and lymphoma.
- Cell Sorting: Specialized flow cytometers can physically isolate specific cells from a heterogeneous mixture, which is valuable for research and therapeutic applications.
- Clinical Diagnostics: Flow cytometry is increasingly used in clinical settings for diagnosing diseases, monitoring treatment responses, and assessing immune status in patients with conditions like cancer and autoimmune disorders.
- Research Applications: The technique is widely used in research for analyzing cell cycle progression, apoptosis, and cell proliferation assays.
- Microbiology: Flow cytometry can also be applied in clinical microbiology for the detection of pathogens in samples, allowing for rapid diagnosis.
Competitive Landscape
The flow cytometry market is highly fragmented. There are large number flow cytometry manufacturer in the global market involved in developing innovative products so that they can meet their customer’s needs.
Prominent manufacturer of flow cytometry products are focused on growing internationally in order to increase their revenue and increase the size of their sales footprint in developing nations through the purchase of regional competitors. Manufacturers utilize various key strategies such as agreements, product launches, research sponsorship, and strategic collaborations to boost product sales and establish their market presence.
Recent Industry Developments in Flow Cytometry Market
- On May 1, 2024, Agilent Technologies, Inc., a medical technology company, announced that they have launched NovoCyte Opteon Spectral Flow, a next generation flow cytometer used for research and clinical purpose.
- In January 2024, IDEX Health & Science LLC., announced that they have launched Semrock® Nanopede™ Optical Filters especially for use for flow cytometry applications.
- In March 2023, Becton Dickinson and Company and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, jointly announced that they have partnered to conduct research on deep immunophenotyping of human tissues using spectral flow cytometry panels.
Key Players of Flow Cytometry Industry
- BD Biosciences
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Sony Biotechnology Inc.
- Sysmex Partec GmbH
- Miltenyi Biotec
- Luminex Corporation
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Cytek Biosciences, Inc.
Key Segments of Flow Cytometry Industry
By Product Type:
In terms of product type, the industry is divided into flow cytometer system [tradition flow cytometer, cell sorters (imaging flow cytometers and acoustic focusing cytometers) and next-generation flow cytometers], reagents, consumables & accessories, software and services
By Application:
In terms of application, the industry is divided into immunophenotyping, cell sorting, cell cycle analysis (apoptosis, cell proliferation assays and intracellular calcium flux), and detection & sorting of exosomes and others.
By Usage:
In terms of usage, the industry is segregated into research use and clinical diagnostics
By End User:
In terms of end user, the industry is segregated into hospitals, diagnostic laboratories, academic and research institute and biopharmaceutical companies
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
3D Printed Hip And Knee Implants Market
3D Printed Medical Implants Market
Contact-Free Sleep Monitoring Systems Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube